newsfilter
← Latest News
GlobeNewswire·

Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

FARMINGTON HILLS, Mich., July 10, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (NASDAQ:OCUP), today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent